via Johns Hopkins University
Perhaps no region of the brain is more fittingly named than the claustrum, taken from the Latin word for “hidden or shut away.” The claustrum is an extremely thin sheet of neurons deep within the cortex, yet it reaches out to every other region of the brain. Its true purpose remains “hidden away” as well, with researchers speculating about many functions. For example, Francis Crick of DNA-discovery fame believed that the claustrum is the seat of consciousness, responsible for awareness and sense of self.
What is known is that this region contains a large number of receptors targeted by psychedelic drugs such as LSD or psilocybin ¾ the hallucinogenic chemical found in certain mushrooms. To see what happens in the claustrum when people are on psychedelics, Johns Hopkins Medicine researchers compared the brain scans of people after they took psilocybin with their scans after taking a placebo.
The scans after psilocybin use showed that the claustrum was less active, meaning the area of the brain believed responsible for setting attention and switching tasks is turned down when on the drug. The researchers say that this ties in with what people report as typical effects of psychedelic drugs, including feelings of being connected to everything and reduced senses of self or ego.
“Our findings move us one step closer to understanding mechanisms underlying how psilocybin works in the brain,” says Frederick Barrett, Ph.D., assistant professor of psychiatry and behavioral sciences at the Johns Hopkins University School of Medicine and a member of the school’s Center for Psychedelic and Consciousness Research. “This will hopefully enable us to better understand why it’s an effective therapy for certain psychiatric disorders, which might help us tailor therapies to help people more.”
Because of its deep-rooted location in the brain, the claustrum has been difficult to access and study. Last year, Barrett and his colleagues at the University of Maryland, Baltimore, developed a method to detect brain activity in the claustrum using functional magnetic resonance imaging (fMRI).
For this new study, the researchers used fMRI with 15 people and observed the claustrum brain region after the participants took either psilocybin or a placebo. They found that psilocybin reduced neural activity in the claustrum by 15% to 30%. This lowered activity also appeared to be associated with stronger subjective effects of the drug, such as emotional and mystical experiences. The researchers also found that psilocybin changed the way that the claustrum communicated with brain regions involved in hearing, attention, decision-making and remembering.
With the highly detailed imaging of the claustrum provided by fMRI, the researchers next hope to look at the mysterious brain region in people with certain psychiatric disorders such as depression and substance use disorder. The goal of these experiments will be to see what roles, if any, the claustrum plays in these conditions. The researchers also plan to observe the claustrum’s activity when under the influence of other psychedelics, such as salvinorin A, a hallucinogen derived from a Mexican plant.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Psychedelic mushrooms at center of effort to help dying patientson November 28, 2020 at 4:28 pm
“Frankly, I was terrified.” But instead of retreating into her illness, Baldeschwiler is pouring energy into a new effort to help dying patients gain legal access to psilocybin — the mind-altering ...
- Will ‘magic mushrooms’ go the way of cannabis? Legalization efforts are growingon November 28, 2020 at 3:27 am
Some advocates are pushing to decriminalize all drugs and possibly create a commercial market for a range of psychedelic substances, while most medical experts urge caution.
- Legalizing Therapeutic Access To Psilocybinon November 27, 2020 at 6:59 am
The measure explicitly does nothing to end psilocybin prohibition outside the licensed system. Still, there will be some protections to individual consumers of psilocybin if Measure 110, a general ...
- ‘Magic mushrooms’ moving into the mainstreamon November 27, 2020 at 12:30 am
Efforts to decriminalize psychedelics could follow several different paths ...
- 2 psilocybin therapy patients share their experienceson November 23, 2020 at 8:37 am
The measure that legalized the therapy directs the Oregon Health Authority to create a state-licensed, psilocybin-assisted therapy program over the next two years. We hear from two people who have ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- Mike Tyson Says Psychedelics Inspired Boxing Returnon November 28, 2020 at 1:42 pm
Mike Tyson is getting back into the ring, all as a result of one of the world's most powerful psychedelics. Ahead of his return match against Roy Jones Jr. Saturday night, Tyson revealed he was ...
- Bloomberg Best: Psychedelics, Yellen, Pita Chips (Podcast)on November 27, 2020 at 12:47 pm
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world. Julia ...
- These Four Former Pro Athletes Are Using Psychedelics To Heal Their Brain Injurieson November 26, 2020 at 3:00 am
Former pro athletes are part of a growing movement of people using plant medicines like ayahuasca and magic mushrooms to help heal PTSD and the symptoms of brain trauma, as seen in a recent episode of ...
- Hemp And CBD Media Outlet PuraPhy Expands To Functional Mushrooms And Psychedelicson November 25, 2020 at 8:09 am
Between the incredible progress both cannabis and psychedelics have made in recent years, the options for establishing and maintaining wellness have rapidly expanded. Now, more than ever before, there ...
- Peter Thiel backs Berlin start-up making psychedelics in $125 million roundon November 23, 2020 at 7:39 am
ATAI Life Sciences, which describes itself as a drug development platform, was set up to acquire, incubate and develop psychedelics and other drugs that can be used to treat depression ...